# Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells

> **NCT03798301** · PHASE1 · TERMINATED · sponsor: **University of Wisconsin, Madison** · enrollment: 3 (actual)

## Conditions studied

- CMV Infection
- Cytomegalovirus Infections
- CMV Viremia
- Opportunistic Infections

## Interventions

- **BIOLOGICAL:** CMV-specific T-cells

## Key facts

- **NCT ID:** NCT03798301
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-02-06
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-05-31
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2024-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03798301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03798301, "Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03798301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*